61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
PerkinElmer Inc
Closed
Sector Healthcare
0
Overview
Share price change
24h
Min
Max
Income | 39M 94M |
|---|---|
Sales | -8M 684M |
P/E Sector Avg | 79.84 59.526 |
EPS | 1.28 |
Dividend yield | 0.219 |
Profit margin | 13.796 |
EBITDA | -7.2M 212M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +5.62 upside |
Dividend yield Sector Avg | 0.22% 2.33% |
|---|---|
Next Earnings | 31 Jan 2025 |
Next Dividend date | 7 Feb 2025 |
Next Ex Dividend date | 18 Apr 2025 |
Market Cap | 550M 14B |
|---|---|
Previous open | 0 |
Previous close | 0 |
News Sentiment
By Acuity
20%
80%
37 / 392 Healthcare
PerkinElmer Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
PerkinElmer Inc Forecast
Price Target
By TipRanks
5.62% upside
12 Months Forecast
Average 130.92 USD 5.62%
High 145 USD
Low 105 USD
Based on 14 Wall Street analysts offering 12 month price targets forPerkinElmer Inc - Dist in the last 3 months.
Sentiment
By Acuity
37 / 392 Healthcare
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About PerkinElmer Inc
PerkinElmer, Inc. is a provider of products, services and solutions for the diagnostics, life sciences and applied markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides products and services targeted towards the life sciences and applied markets. The Diagnostics segment develops diagnostics, tools and applications focused on clinically oriented customers, especially within the reproductive health, immunodiagnostics and applied genomics markets. The Company provides early detection for genetic disorders from pregnancy to early childhood, and infectious disease testing for the diagnostics market. It offers its products under various brand names, including AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific, BoBs, chemagic, Chitas, Datalytix, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROline, EUROPattern, FragilEase, Genoglyphix, GSP, and Haoyuan.
